WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health-care settings
Las nuevas jeringas "inteligentes" que la OMS recomienda para la administración de inyecciones por vía intramuscular, intradérmica y subcutánea tienen características que impiden su reutilización. Algunos modelos tienen un punto débil en el émbolo que provoca su rotura, si el usuario intenta tirar h...
I tiakina i:
| Kaituhi rangatōpū: | |
|---|---|
| Hōputu: | Monograph |
| Reo: | Ingarihi |
| I whakaputaina: |
Ginebra
World Health Organization
2015
|
| Ngā marau: | |
| Urunga tuihono: | Enlace web Path |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Ngā tūemi rite: WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health-care settings
- Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs
- Heating injection drug preparation equipment used for opioid injection may reduce HIV transmission associated with sharing equipment
- Evidence for the effectiveness of interventions to prevent infections: Drug treatment, needle and syringe programmes and drug consumption rooms for preventing hepatitis C, HIV and injecting risk behaviour among people who inject drugs
- Increasing access to hepatitis C testing and care for people who inject drugs. Identifying barriers to and opportunities for supporting hepatitis C testing and care in drug services: a participatory diagnostic process
- Needle & Syringe Programs in prisions. An international review
- Prevention and control of infectious diseases among people who inject drugs